Egyptian International Pharmaceutical Industries Company (CASE: PHAR)
Health Care · Pharmaceuticals · EG
EGP114.10
-1.47% today · +69.0% 1Y
Egyptian International Pharmaceutical Industries Company (CASE: PHAR) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $367.68M.
Over the last twelve months the share price has gained 69.0%, trading between 67.14 and 178.99.
Tweenvest scores Egyptian International Pharmaceutical Industries Company across four factors: quality 56/100, value 36/100, growth 50/100, dividend 58/100. Its strongest factor is dividend.
PHAR price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $367.68M
- Revenue (TTM)
- $201.18M
- P/E
- 14.92
- EPS
- 7.65
- Dividend yield
- 1.31%
- Beta (5Y)
- 0.57
- 52-week high
- EGP178.99
- 52-week low
- EGP67.14
- Avg volume (3M)
- —
- Shares outstanding
- 168.76M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Shinpoong Pharmaceutical Co.,LtdKOSE: A019170 | $375.67M | ₩9,780.00 | +5.73% |
| Honz Pharmaceutical Co., Ltd.SZSE: 300086 | $373.04M | CN¥5.49 | +2.23% |
| Zhejiang Shengda Bio-Pharm Co., Ltd.SHSE: 603079 | $372.46M | CN¥13.31 | -2.20% |
| Taho Pharmaceuticals Ltd.TPEX: 6467 | $368.78M | NT$225.00 | -2.60% |
| GlaxoSmithKline Pakistan LimitedKASE: GLAXO | $364.11M | PKRs316.60 | +1.20% |
| Zhejiang Xinguang Pharmaceutical Co., Ltd.SZSE: 300519 | $362.13M | CN¥15.16 | +2.29% |
| Relmada Therapeutics, Inc.NasdaqCM: RLMD | $361.61M | $3.41 | +0.59% |
| ASKA Pharmaceutical Holdings Co.,Ltd.TSE: 4886 | $359.39M | ¥2,004.00 | -1.28% |
Figures last refreshed Oct 11, 2026.